Risk factors for new vertebral fractures after percutaneous vertebroplasty or percutaneous kyphoplasty in the treatment of osteoporotic vertebral compression fractures

被引:0
|
作者
Yang, Wencheng [1 ]
Zou, Kaiwei [1 ]
Lin, Xuping [1 ]
Yang, Yanfang [2 ]
Chen, Tianpei [1 ]
Wu, Xiuming [1 ]
Wang, Xiaomeng [1 ]
Liu, Qingjun [3 ]
Huang, Chunhui [1 ]
Su, Wanhan [1 ]
机构
[1] Fujian Med Univ, Longyan First Affiliated Hosp, Dept Spine Surg, Longyan, Peoples R China
[2] Fujian Med Univ, Shengli Clin Med Coll, Dept Cardiol, Fuzhou, Fujian, Peoples R China
[3] Xiamen Univ, Affiliated Dongnan Hosp, Dept Orthopaed, Zhangzhou, Peoples R China
关键词
osteoporotic vertebral compression fractures; senior citizen; new vertebral fractures; percutaneous vertebroplasty; percutaneous kyphoplasty; risk factors; EFFICACY;
D O I
10.3389/fmed.2025.1514894
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Object: This study aims to conduct a prospective analysis of patients with osteoporotic vertebral compression fractures (OVCF) who underwent percutaneous vertebroplasty (PVP) or percutaneous kyphoplasty (PKP), and further analyze the risk factors for new vertebral fracture following treatment. Methods: A prospective study was conducted from November 2020 to March 2022 at the First Hospital of Longyan City to select patients with OVCF who underwent treatment in the Department of Spinal Surgery. Data collection during the follow-up period focused on various factors that could potentially be associated with new vertebral fractures after PVP/PKP procedures. Patients were divided into two groups based on whether they experienced new vertebral fractures within two years after discharge: the new fracture group (n = 186) and the non-fracture group (n = 64), and statistical analysis was conducted accordingly. Results: All cases were followed up for 12 to 24 months, with an average of 14.7 months. Differential analysis revealed that age, diabetes, hemoglobin (HB), total protein (TP), serum albumin (ALB), b-C-terminal telopeptide of type I collage (beta-CTX), 25-hydroxyvitamin D (25-OH-D3), number of fractured vertebrae, bone mineral density (BMD), regular exercise after discharge, anti-osteoporosis treatment after discharge, cross-sectional area (CSA), and fatty degeneration ratio (FDR) were associated with new vertebral fractures (all P < 0.05). Multivariate analysis showed that age (OR = 1.519, P = 0.032), diabetes (OR = 3.273, P = 0.048), and FDR (OR = 1.571, P = 0.027) were positively associated with the occurrence of new vertebral fractures, while bone mineral density (OR = 0.108, P = 0.044), 25-OH-D3 (OR = 0.871, P = 0.032), CSA (OR = 0.564, P = 0.009), regular postoperative exercise (OR = 0.259, P = 0.025), and osteoporosis treatment (OR = 0.291, P = 0.045) were negatively associated with the occurrence of new vertebral fractures. Conclusion: Patients with osteoporosis fractures who are older, have poor glycemic control, lower bone mineral density, lower levels of 25-OH-D3, weaker paraspinal muscles, and higher fat infiltration are at increased risk of new vertebral fractures after undergoing PKP/PVP. On the other hand, maintaining regular physical activity and adhering to osteoporosis treatment can help prevent new vertebral fractures.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Risk factors of developing new symptomatic vertebral compression fractures after percutaneous vertebroplasty in osteoporotic patients
    Wan Soo Lee
    Kyeong Hoon Sung
    Hyun Tae Jeong
    Youn Sang Sung
    Yong In Hyun
    Jae Young Choi
    Kyu Seok Lee
    Chul Su Ok
    Young Woo Choi
    European Spine Journal, 2006, 15
  • [22] The clinical effect of percutaneous kyphoplasty for the treatment of multiple osteoporotic vertebral compression fractures and the prevention of new vertebral fractures
    Zhai, Weifeng
    Jia, Yongwei
    Wang, Jianjie
    Cheng, Liming
    Zeng, Zhili
    Yu, Yan
    Chen, Lei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (08): : 13473 - 13481
  • [23] Risk factors for secondary fractures to percutaneous vertebroplasty for osteoporotic vertebral compression fractures: a systematic review
    Wei Mao
    Fei Dong
    Guowei Huang
    Peiliang He
    Huan Chen
    Shengnan Qin
    Aiguo Li
    Journal of Orthopaedic Surgery and Research, 16
  • [24] Risk factors for secondary fractures to percutaneous vertebroplasty for osteoporotic vertebral compression fractures: a systematic review
    Mao, Wei
    Dong, Fei
    Huang, Guowei
    He, Peiliang
    Chen, Huan
    Qin, Shengnan
    Li, Aiguo
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2021, 16 (01)
  • [25] Risk factors of developing new symptomatic vertebral compression fractures after percutaneous vertebroplasty in osteoporotic patients
    Lee, Wan Soo
    Sung, Kyeong Hoon
    Jeong, Hyun Tae
    Sung, Youn Sang
    Hyun, Yong In
    Choi, Jae Young
    Lee, Kyu Seok
    Ok, Chul Su
    Choi, Young Woo
    EUROPEAN SPINE JOURNAL, 2006, 15 (12) : 1777 - 1783
  • [26] Percutaneous vertebroplasty: New treatment for vertebral compression fractures
    Predey, TA
    Sewall, LE
    Smith, SJ
    AMERICAN FAMILY PHYSICIAN, 2002, 66 (04) : 611 - 615
  • [27] PERCUTANEOUS VERTEBROPLASTY FOR OSTEOPOROTIC VERTEBRAL FRACTURES
    Bautista Del Valle, Juan
    Miguel Galich, Facundo
    Adrian Borensztein, Matias
    Gustavo Petracchi, Matias
    ACTUALIZACIONES EN OSTEOLOGIA, 2022, 18 (01) : 29 - 39
  • [28] Comparison of Percutaneous Kyphoplasty Versus Modified Percutaneous Kyphoplasty for Treatment of Osteoporotic Vertebral Compression Fractures
    Qi, Yimin
    Zeng, Yiwen
    Jiang, Chunzhi
    Liang, Bin
    Sui, Jisheng
    Zhao, Lei
    Wang, Dalin
    WORLD NEUROSURGERY, 2019, 122 : E1020 - E1027
  • [29] Risk factors of new vertebral compression fracture after percutaneous vertebroplasty or percutaneous kyphoplasty
    Cheng, Yuanpei
    Cheng, Xiaokang
    Wu, Han
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [30] Risk factors of new symptomatic vertebral compression fractures in osteoporotic patients undergone percutaneous vertebroplasty
    Ren, Hai-long
    Jiang, Jian-ming
    Chen, Jian-ting
    Wang, Ji-xing
    EUROPEAN SPINE JOURNAL, 2015, 24 (04) : 750 - 758